Agile Therapeutics
AGRX
$0.36
Share price
-0.82%
Change (1 day)
-90.30%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Net assets
Net assets on the balance sheet as of March 2024 : -$10.33 M
According to Agile Therapeutics
's latest financial reports the company has -$10.33 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Agile Therapeutics - Net assets on balance sheet (from 2013 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-5.55 M | -241.63% |
| 2021-12-31 | $3.91 M | -92.06% |
| 2020-12-31 | $49.32 M | 7.83% |
| 2019-12-31 | $45.74 M | 126.75% |
| 2018-12-31 | $20.17 M | -44.46% |
| 2017-12-31 | $36.32 M | -14.11% |
| 2016-12-31 | $42.28 M | 42.18% |
| 2015-12-31 | $29.74 M | -17.39% |
| 2014-12-31 | $36 M | -150.4% |
| 2013-12-31 | $-71.45 M | 21.9% |
| 2012-12-31 | $-58.61 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | -678,325.49% | 🇺🇸 USA |
 Pfizer PFE | $92.55 B | -896,632.35% | 🇺🇸 USA |
 Merck MRK | $40.42 B | -391,653.66% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $28.66 M | -377.64% | 🇺🇸 USA |